May 10, 2012
Bayer Yakuhin entered into a copromotion agreement in Japan on May 7 with Santen Pharmaceutical for its wet age-related macular degeneration (wet AMD) treatment VEGF Trap-Eye (aflibercept) for which the company filed a new drug application (NDA) in Japan, and...read more